Gilberto L Pardo-Andreu Selected Research

Gilberto L Pardo-Andreu Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 02/2006
5	Brain Ischemia (Cerebral Ischemia) 01/2022 - 10/2014
3	Neuroinflammatory Diseases 01/2022 - 11/2015
3	Reperfusion Injury 05/2021 - 10/2014
3	Ischemia 05/2021 - 12/2012
3	Hypoxia (Hypoxemia) 03/2014 - 10/2006
2	Infarction (Infarctions) 01/2019 - 10/2014
2	Body Weight (Weight, Body) 01/2019 - 01/2008
2	Atherosclerosis 06/2018 - 05/2008
2	Stroke (Strokes) 10/2014 - 10/2013
2	Iron Overload 01/2008 - 11/2006
1	Memory Disorders (Memory Loss) 05/2019
1	Cognitive Dysfunction 05/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2018
1	Dementia (Dementias) 07/2017
1	Gliosis 11/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2014
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2014
1	Ischemic Stroke 12/2012
1	Carcinoma (Carcinomatosis) 06/2011
1	Necrosis 07/2007
1	Friedreich Ataxia (Friedreich's Ataxia) 11/2006
1	Hemochromatosis (Bronze Diabetes) 11/2006
1	beta-Thalassemia (Cooley's Anemia) 11/2006
1	Pathologic Processes 10/2006

Drug/Important Bio-Agent (IBA)

6	Neuroprotective AgentsIBA 01/2022 - 12/2012
5	AntioxidantsIBA 06/2018 - 02/2006
5	Mangifera indica extractIBA 06/2018 - 02/2006
3	nemorosoneIBA 01/2023 - 03/2011
3	PhycocyaninIBA 01/2022 - 12/2012
3	Glutamic Acid (Glutamate)FDA Link 05/2021 - 03/2014
3	mangiferinIBA 05/2008 - 10/2006
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008 - 10/2006
2	Scopolamine (Hyoscine)FDA Link 05/2019 - 07/2017
2	LDL Receptors (LDL Receptor)IBA 06/2018 - 05/2008
2	Cytochromes c (Cytochrome c)IBA 10/2014 - 10/2014
2	tert-ButylhydroperoxideIBA 12/2012 - 11/2006
2	IronIBA 01/2008 - 10/2006
2	Superoxides (Superoxide)IBA 11/2006 - 10/2006
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	malonic acid (malonate)IBA 05/2021
1	EnzymesIBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	RotenoneIBA 01/2019
1	CholesterolIBA 06/2018
1	Cholinergic Agents (Cholinergics)IBA 07/2017
1	Oxygen (Dioxygen)IBA 11/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	Anti-Anxiety Agents (Anxiolytics)IBA 10/2014
1	Excitatory Amino AcidsIBA 10/2014
1	Aspartic Acid (Aspartate)FDA Link 10/2014
1	Mitochondrial Permeability Transition PoreIBA 10/2014
1	1,4-dihydropyridine (dihydropyridine)IBA 10/2014
1	LigandsIBA 10/2014
1	Diazepam (Valium)FDA LinkGeneric 10/2014
1	7-epiclusianoneIBA 04/2014
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2014
1	phycocyanobilinIBA 10/2013
1	TetrapyrrolesIBA 10/2013
1	Phosphates (Orthophosphate)IBA 12/2012
1	calcium phosphateIBA 12/2012
1	guttiferone AIBA 06/2011
1	Succinic Acid (Succinate)IBA 06/2011
1	benzophenoneIBA 06/2011
1	Adenosine Triphosphate (ATP)IBA 03/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2008
1	oxidized low density lipoproteinIBA 05/2008
1	NADP (NADPH)IBA 05/2008
1	PolyphenolsIBA 05/2008
1	Dextrans (Dextran)FDA Link 01/2008
1	nimesulide (Aulin)IBA 07/2007
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2007
1	1,1-diphenyl-2-picrylhydrazylIBA 11/2006
1	PyrogallolIBA 10/2006

Therapy/Procedure

1	Oral Administration 10/2014
1	Therapeutics 11/2006